• CX-4945 (Silmitasertib): Targeting CK2 for Cancer Stemness a

  2026-06-29

  Explore how CX-4945 (Silmitasertib), a potent CK2 inhibitor, disrupts cancer stem cell phenotypes and chemoresistance by targeting CK2-mediated pathways. This article delivers unique insights into its mechanistic impact in oncology research, with a focus on recent findings in lung cancer aggressiveness.

• Methylprednisolone in Preclinical Assay Design: Mechanisms a

  2026-06-29

  Explore methylprednisolone, a synthetic glucocorticoid receptor agonist, through the lens of assay design and mechanistic insight. This article uniquely deciphers translational mechanisms, protocol parameters, and recent innovations, offering researchers a precise guide to maximizing anti-inflammatory model fidelity.

• Ceftolozane/Tazobactam: Addressing Gram-Negative Resistance

  2026-06-28

  The reference study introduces ceftolozane/tazobactam as a novel cephalosporin/b-lactamase inhibitor with enhanced efficacy against multidrug-resistant gram-negative pathogens, specifically addressing complicated intraabdominal and urinary tract infections. Its pharmacodynamic profile and clinical performance mark a significant advance in antimicrobial therapy, with implications for both resistance management and future drug development.

• PA-Src-FAK-ROCK Pathway Drives Cytoskeletal Changes in Decid

  2026-06-27

  This study reveals that phosphatidic acid (PA) induces cytoskeletal rearrangements in human endometrial stromal cells through the Src-FAK-RhoA/ROCK pathway, independent of traditional decidual markers. These findings clarify the molecular mechanism of morphological changes during decidualization and highlight new avenues for infertility research.

• Trolox as a Benchmark Antioxidant in Oxidative Injury Resear

  2026-06-26

  Trolox, a cell-permeable vitamin E analogue, is indispensable for standardizing oxidative injury assays and advancing neurodegeneration and cancer biology research. Learn how APExBIO’s Trolox supports optimized workflows, troubleshooting, and cross-domain innovation in antioxidant screening.

• D-N-Acetylgalactosamine: Technical Guidance for Brain Glycop

  2026-06-26

  D-N-Acetylgalactosamine is a high-purity, water-soluble biochemical used for precise analysis of glycoprotein constituents and glycosylation pathways in neurological research. It is not suitable for workflows requiring ethanol solubility or long-term storage of working solutions. Researchers should adhere to product-specific storage and handling protocols to ensure reproducibility and data integrity.

• DMG-PEG2000-NH2: Reliable Linker for Liposomal Drug Delivery

  2026-06-25

  This article explores real-world laboratory scenarios where DMG-PEG2000-NH2 (SKU M2006) elevates the reliability of lipid nanoparticle and liposomal drug delivery workflows. Through scenario-driven Q&A, we detail experimental principles, optimization strategies, and product selection insights, helping biomedical researchers make data-backed choices for cell-based assays and delivery platform construction.

• ZDHHC4-Mediated Palmitoylation Regulates TRPV1 and Pain Reli

  2026-06-25

  This study uncovers a regulatory mechanism in which S-palmitoylation of TRPV1 by ZDHHC4 promotes channel degradation, thereby attenuating inflammatory pain. The findings reveal new post-translational dynamics for pain relief and suggest actionable targets for future analgesic research.

• Suhuang Capsule Modulates ER Stress and NLRP3 in Asthma Mode

  2026-06-24

  This study demonstrates that Suhuang antitussive capsule ameliorates pulmonary dysfunction in cough variant asthma by inhibiting endoplasmic reticulum (ER) stress and downstream NLRP3 inflammasome activation. These findings clarify mechanistic links between ER stress regulation, calcium signaling, and inflammation in respiratory disease, with implications for modeling and intervention strategies.

• Ceftazidime in Gram-Negative Infection Research: Protocols &

  2026-06-23

  Ceftazidime, a third-generation cephalosporin, stands out for its robust β-lactamase resistance and unrivaled activity against Pseudomonas aeruginosa. This article delivers actionable protocols, advanced applications, and troubleshooting insights to elevate Gram-negative infection research, backed by recent multidrug resistance findings and real-world experimental workflows.

• Cy5 NHS ester(Et): Technical Guide for Amino Group Labeling

  2026-06-23

  Cy5 NHS ester(Et) offers water-soluble, high-purity fluorescent labeling for primary amines in proteins and peptides, supporting workflows like immunofluorescence staining, flow cytometry, and fluorescence microscopy. It is not suitable for ethanol-based protocols or for long-term storage of working solutions, and requires immediate use after preparation. Proper workflow design and adherence to handling parameters are critical to avoid reagent loss or reduced labeling efficiency.

• ATS-9R: Transforming Targeted Gene Silencing in Adipose Tiss

  2026-06-22

  Explore the advanced mechanism and unique therapeutic potential of ATS-9R (Adipocyte-targeting sequence-9-arginine) for gene silencing in adipocytes. This in-depth analysis reveals how ATS-9R enables precise, low-toxicity delivery to white adipose tissue, distinguishing it from existing non-viral gene delivery systems.

• Modulating Ionizable Lipids for Organ-Selective mRNA Deliver

  2026-06-22

  The reference study introduces a multidimensional strategy to rapidly synthesize and screen ionizable lipids (ILs) for lipid nanoparticle (LNP)-mediated mRNA delivery, using the Ugi four-component reaction for structural diversity. This approach enables rational selection of ILs for organ-specific, high-efficiency mRNA transfection, with significant implications for targeted gene therapy and mRNA-based therapeutics.

• ECL Chemiluminescent Substrate Detection Kit: Enhanced RCC W

  2026-06-21

  Unlock ultra-sensitive, low-background western blot detection with the ECL Chemiluminescent Substrate Detection Kit (Enhanced). This workflow-driven guide details advanced protein immunodetection strategies, integrates reference RCC research, and delivers practical troubleshooting for reproducible results.

• In Vitro Activity of Sisomicin Against Clinical Isolates

  2026-06-20

  This article examines a foundational study that rigorously compared the in vitro antibacterial activity of Sisomicin—a broad-spectrum aminoglycoside antibiotic—against a diverse panel of clinical isolates. The findings clarify Sisomicin’s comparative efficacy, methodological nuances, and implications for experimental design in Gram-negative and Gram-positive bacterial infection research.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page